Adult Presentation of Ornithine Transcarbamylase Deficiency: 2 Illustrative Cases of Phenotypic Variability and Literature Review
- PMID: 30671162
- PMCID: PMC6327241
- DOI: 10.1177/1941874418764817
Adult Presentation of Ornithine Transcarbamylase Deficiency: 2 Illustrative Cases of Phenotypic Variability and Literature Review
Abstract
Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that usually presents in the neonatal period. Late-onset presentation of OTC can cause mild to severe symptoms. We describe laboratory and clinical findings of late-onset presentations of OTC deficiency. We conducted a literature search using search terms "ornithine transcarbamylase deficiency," "late onset presentation," and "hyperammonemia" from January 1, 1987, to December 31, 2016, was performed. Only papers published in English were included. We searched on PubMed, MEDLINE, and Google Scholar. We also present 2 OTC deficiency cases. A total of 30 adult cases had late-onset presentation of OTC deficiency reported. The majority were women (57%) with a median age of 37 years. The median level of ammonia was 308 mmol/L and the mortality rate was 30%. Our case 1 was a 40-year-old woman who succumbed to neurologic complications after a hyperammonemia crisis following an increased protein intake. Our case 2 was a 43-year-old woman with seizures associated with increased ammonia levels. Our 2 case reports show the wide phenotypic variability and severity in late-onset presentation of OTC ranging from seizures to cerebral herniation. Our literature review is the first to detail published laboratory and neurologic sequelae of late-onset OTC deficiency.
Keywords: hyperammonemia; intracranial hypertension; late-onset disorders; ornithine transcarbamylase deficiency; seizure.
Conflict of interest statement
Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


Similar articles
-
Late-onset of ornithine transcarbamylase deficiency: A rare medical examiner case.J Forensic Sci. 2022 Mar;67(2):813-819. doi: 10.1111/1556-4029.14934. Epub 2021 Nov 2. J Forensic Sci. 2022. PMID: 34726276
-
Late-onset ornithine transcarbamylase deficiency: a rare cause of recurrent abnormal behavior in adults.Acute Med Surg. 2020 Sep 8;7(1):e565. doi: 10.1002/ams2.565. eCollection 2020 Jan-Dec. Acute Med Surg. 2020. PMID: 32995020 Free PMC article.
-
Neonatal Presentation of Ornithine Transcarbamylase Deficiency Associated With a Hypomorphic OTC Variant (p.Leu301Phe) Previously Reported in Later-Onset Disease.Cureus. 2024 Aug 1;16(8):e65956. doi: 10.7759/cureus.65956. eCollection 2024 Aug. Cureus. 2024. PMID: 39221296 Free PMC article.
-
Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency.Children (Basel). 2023 Aug 9;10(8):1368. doi: 10.3390/children10081368. Children (Basel). 2023. PMID: 37628367 Free PMC article. Review.
-
[Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Oct 25;49(5):539-547. doi: 10.3785/j.issn.1008-9292.2020.04.11. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33210478 Free PMC article. Review. Chinese.
Cited by
-
Secondary genomic findings in the 2020 China Neonatal Genomes Project participants.World J Pediatr. 2022 Oct;18(10):687-694. doi: 10.1007/s12519-022-00558-w. Epub 2022 Jun 21. World J Pediatr. 2022. PMID: 35727495
-
Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency and in silico analysis of OTC gene.Orphanet J Rare Dis. 2025 Mar 18;20(1):131. doi: 10.1186/s13023-025-03624-4. Orphanet J Rare Dis. 2025. PMID: 40102887 Free PMC article.
-
Urea cycle defects in adulthood: clinical presentation, diagnosis and treatment in genetically encoded hepatic metabolic disorders with a potential for encephalopathy.Metab Brain Dis. 2025 Apr 26;40(5):192. doi: 10.1007/s11011-025-01619-5. Metab Brain Dis. 2025. PMID: 40285952 Free PMC article. Review.
-
Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency.Orphanet J Rare Dis. 2020 Dec 3;15(1):340. doi: 10.1186/s13023-020-01606-2. Orphanet J Rare Dis. 2020. PMID: 33272297 Free PMC article.
-
Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports.Medicine (Baltimore). 2019 Aug;98(33):e16827. doi: 10.1097/MD.0000000000016827. Medicine (Baltimore). 2019. PMID: 31415401 Free PMC article.
References
-
- Walker V. Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab. 2009;11(9):823–835. - PubMed
-
- Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics. 2000;105(1):e10. - PubMed
-
- Bailly P, Noury JB, Timsit S, Ben Salem D. Teaching neuroimages: ornithine transcarbamylase deficiency revealed by a coma in a pregnant woman. Neurology. 2015;85(20):e146–e147. - PubMed
-
- Ben-Ari Z, Dalal A, Morry A, et al. Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins’ diet. J Hepatol. 2010;52(2):292–295. - PubMed
Publication types
LinkOut - more resources
Full Text Sources